Citations (70)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Simone Esposito, Laura Orsatti & Vincenzo Pucci. (2022) Subcutaneous catabolism of peptide therapeutics: bioanalytical approaches and ADME considerations. Xenobiotica 52:8, pages 828-839.
Read now
Read now
Ahmed A. El-Sherbeni & Ayman O. S. El-Kadi. (2017) Microsomal cytochrome P450 as a target for drug discovery and repurposing. Drug Metabolism Reviews 49:1, pages 1-17.
Read now
Read now
Harvey J. Clewell, Justin Teeguarden, Tracy McDonald, Ramesh Sarangapani, Greg Lawrence, Tammie Covington, Robinan Gentry & Annette Shipp. (2002) Review and Evaluation of the Potential Impact of Age- and Gender-Specific Pharmacokinetic Differences on Tissue Dosimetry. Critical Reviews in Toxicology 32:5, pages 329-389.
Read now
Read now
GloriaA. Skowronski & MohamedS. Abdel‐Rahman. (1997) Interspecies comparison of kinetic data of chlorinated chemicals of potential relevance to risk assessment. Human and Ecological Risk Assessment: An International Journal 3:4, pages 635-653.
Read now
Read now
Melvin E. Andersen. (1995) What do we Mean by Dose. Inhalation Toxicology 7:6, pages 909-915.
Read now
Read now
Hon‐Wing Leung. (1991) Development and utilization of physiologically based pharmacokinetic models for toxicological applications. Journal of Toxicology and Environmental Health 32:3, pages 247-267.
Read now
Read now
Bruce Clark, Dennis A. Smith & John Caldwell. (1984) Pharmacokinetics and Toxicity Testing. CRC Critical Reviews in Toxicology 12:4, pages 343-385.
Read now
Read now
Garth Powis. (1983) Dose-Dependent Metabolism, Therapeutic Effect, and Toxicity of Anticancer Drugs in Man. Drug Metabolism Reviews 14:6, pages 1145-1163.
Read now
Read now
Melvin e. Andersen. (1982) Recent Advances in Methodology and Concepts for Characterizing Inhalation Pharmacokinetic Parameters in Animals and Man. Drug Metabolism Reviews 13:5, pages 799-826.
Read now
Read now
Articles from other publishers (61)
Lyle D. Burgoon, Christopher J. Borgert, Claudio Fuentes & James E. Klaunig. (2023) Kinetically-derived maximal dose (KMD) indicates lack of human carcinogenicity of ethylbenzene. Archives of Toxicology.
Crossref
Crossref
Xiaoqing Xu, Yixin Yu, Min Ling, Irma Ares, Marta Martínez, Bernardo Lopez-Torres, Jorge-Enrique Maximiliano, María-Rosa Martínez-Larrañaga, Xu Wang, Arturo Anadón & María-Aránzazu Martínez. (2023) Oxidative stress and mitochondrial damage in lambda-cyhalothrin toxicity: A comprehensive review of antioxidant mechanisms. Environmental Pollution 338, pages 122694.
Crossref
Crossref
C. J. Borgert, C. Fuentes & L. D. Burgoon. (2021) Principles of dose-setting in toxicology studies: the importance of kinetics for ensuring human safety. Archives of Toxicology 95:12, pages 3651-3664.
Crossref
Crossref
Franklin E. Mirer. 2001. Patty's Industrial Hygiene. Patty's Industrial Hygiene
1
27
.
Sahar M. Jaffal, Sawsan A. Oran & Mohammad Alsalem. (2020) Anti-nociceptive effect of Arbutus andrachne L. methanolic leaf extract mediated by CB1, TRPV1 and PPARs in mouse pain models. Inflammopharmacology 28:6, pages 1567-1577.
Crossref
Crossref
G. Johanson. 2018. Comprehensive Toxicology. Comprehensive Toxicology
165
187
.
Harvey III, Rebecca Clewell & Melvin Andersen. 2014. Hayes' Principles and Methods of Toxicology, Sixth Edition. Hayes' Principles and Methods of Toxicology, Sixth Edition
247
294
.
Miyoung Yoon, Alina Efremenko, Bas J. Blaauboer & Harvey J. Clewell. (2014) Evaluation of simple in vitro to in vivo extrapolation approaches for environmental compounds. Toxicology in Vitro 28:2, pages 164-170.
Crossref
Crossref
S. M. Rappaport, S. Kim, R. Thomas, B. A. Johnson, F. Y. Bois & L. L. Kupper. (2012) Low-dose metabolism of benzene in humans: science and obfuscation. Carcinogenesis 34:1, pages 2-9.
Crossref
Crossref
Jerry L. CampbellJr.Jr., Rebecca A. Clewell, P. Robinan Gentry, Melvin E. Andersen & Harvey J. ClewellIIIIII. 2012. Computational Toxicology. Computational Toxicology
439
499
.
Wolfgang Dekant & Spiridon Vamvakas. 2000. Ullmann's Encyclopedia of Industrial Chemistry. Ullmann's Encyclopedia of Industrial Chemistry.
Jelle Vlaanderen, Lützen Portengen, Stephen M. Rappaport, Deborah C. Glass, Hans Kromhout & Roel Vermeulen. (2011) The Impact of Saturable Metabolism on Exposure-Response Relations in 2 Studies of Benzene-induced Leukemia. American Journal of Epidemiology 174:5, pages 621-629.
Crossref
Crossref
Franklin E. Mirer. 2001. Patty's Industrial Hygiene. Patty's Industrial Hygiene
41
88
.
Jerry L. CampbellJr.Jr., Kannan Krishnan, Harvey J. ClewellIIIIII & Melvin E. Andersen. 2010. Principles and Practice of Mixtures Toxicology. Principles and Practice of Mixtures Toxicology
125
157
.
Jerry N. Blancato. 2010. Cancer Risk Assessment. Cancer Risk Assessment
597
612
.
Harvey J. ClewellIIIIII. 2010. Quantitative Modeling in Toxicology. Quantitative Modeling in Toxicology
399
428
.
Harvey J. ClewellIIIIII, Micaela B. Reddy, Thierry Lave & Melvin E. Andersen. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
62
.
G. Johanson. 2010. Comprehensive Toxicology. Comprehensive Toxicology
153
177
.
D. J. Taylor, L. L. Kupper, B. A. Johnson, S. Kim & S. M. Rappaport. (2008) Statistical models for exposure-biomarker relationships with measurement error and censoring. Journal of Agricultural, Biological, and Environmental Statistics 13:4, pages 367-387.
Crossref
Crossref
Harvey J. ClewellIIIIII, Melvin E. Andersen & Bas J. Blaauboer. (2008) On the incorporation of chemical-specific information in risk assessment. Toxicology Letters 180:2, pages 100-109.
Crossref
Crossref
Rebecca A. Clewell & Harvey J. ClewellIIIIII. (2008) Development and specification of physiologically based pharmacokinetic models for use in risk assessment. Regulatory Toxicology and Pharmacology 50:1, pages 129-143.
Crossref
Crossref
Wolfgang Dekant & Spiridon Vamvakas. 2000. Ullmann's Encyclopedia of Industrial Chemistry. Ullmann's Encyclopedia of Industrial Chemistry.
John S Wheeler & Selene Chou. (2002) Considerations and procedures in the derivation of ATSDR minimal risk levels. Vaccine 20, pages S51-S55.
Crossref
Crossref
Harvey J Clewell3rd3rd, Melvin E Andersen & Hugh A Barton. (2002) A consistent approach for the application of pharmacokinetic modeling in cancer and noncancer risk assessment.. Environmental Health Perspectives 110:1, pages 85-93.
Crossref
Crossref
Patrick Poulin & Kannan Krishnan. (2020) A Quantitative Structure-toxicokinetic Relationship Model for Highly Metabolised Chemicals. Alternatives to Laboratory Animals 26:1, pages 45-55.
Crossref
Crossref
Kannan Krishnan & Michael Pelekis. (1995) Hematotoxic interactions: occurrence, mechanisms and predictability. Toxicology 105:2-3, pages 355-364.
Crossref
Crossref
Melvin E. Andersen, Harvey Clewell III & Kannan Krishnan. (2006) Tissue Dosimetry, Pharmacokinetic Modeling, and Interspecies Scaling Factors. Risk Analysis 15:4, pages 533-537.
Crossref
Crossref
J.M. Frazier. (1995) Application of in vitro systems to the prediction of in vivo biokinetics. Toxicology in Vitro 9:4, pages 527-536.
Crossref
Crossref
D KrewskiJ R WitheyL F KuM E Andersen. (1994) Applications of physiologic pharmacokinetic modeling in carcinogenic risk assessment.. Environmental Health Perspectives 102:suppl 11, pages 37-50.
Crossref
Crossref
Harvey J. ClewellIIIIII & Melvin E. Andersen. (2016) Physiologically-Based Pharmacokinetic Modeling and Bioactivation of Xenobiotics. Toxicology and Industrial Health 10:1-2, pages 1-24.
Crossref
Crossref
S. M. Rappaport. (1993) Biological considerations in assessing exposures to genotoxic and carcinogenic agents. International Archives of Occupational and Environmental Health 65:S1, pages S29-S35.
Crossref
Crossref
M. E. Andersen, K. Krishnan, R. B. Conolly & R. O. McClellan. 1992. Medical Toxicology. Medical Toxicology
217
227
.
Elizabeth L. Anderson. 1992. Oncogene and Transgenics Correlates of Cancer Risk Assessments. Oncogene and Transgenics Correlates of Cancer Risk Assessments
1
20
.
A.M. Monro. (1990) Interspecies comparisons in toxicology: The utility and futility of plasma concentrations of the test substance. Regulatory Toxicology and Pharmacology 12:2, pages 137-160.
Crossref
Crossref
Dalton Paxman & S.M. Rappaport. (1990) Analysis of OSHA's short-term-exposure limit for benzene. Regulatory Toxicology and Pharmacology 11:3, pages 275-287.
Crossref
Crossref
Melvin E. Andersen. (1989) Tissue dosimetry, physiologically-based pharmacokinetic modeling, and cancer risk assessment. Cell Biology and Toxicology 5:4, pages 405-415.
Crossref
Crossref
Michael L. Gargas & Melvin E. Andersen. (1989) Determining kinetic constants of chlorinated ethane metabolism in the rat from rates of exhalation. Toxicology and Applied Pharmacology 99:2, pages 344-353.
Crossref
Crossref
M.A. Medinsky, P.J. Sabourin, G. Lucier, L.S. Birnbaum & R.F. Henderson. (1989) A physiological model for simulation of benzene metabolism by rats and mice. Toxicology and Applied Pharmacology 99:2, pages 193-206.
Crossref
Crossref
A Koizumi. (1989) Potential of physiologically based pharmacokinetics to amalgamate kinetic data of trichloroethylene and tetrachloroethylene obtained in rats and man.. Occupational and Environmental Medicine 46:4, pages 239-249.
Crossref
Crossref
Robert J. Scheuplein. 1989. Risk Assessment in Setting National Priorities. Risk Assessment in Setting National Priorities
279
285
.
. (2016) 3: Final Report on the Safety Assessment of Methylene Chloride. Journal of the American College of Toxicology 7:6, pages 741-835.
Crossref
Crossref
F G Standaert. (1988) Absorption and distribution of xenobiotics.. Environmental Health Perspectives 77, pages 63-71.
Crossref
Crossref
Elizabeth L. Anderson. 1988. Carcinogen Risk Assessment. Carcinogen Risk Assessment
3
17
.
Egon Marth. (1987) Metabolic changes following oral exposure to tetrachloroethylene in subtoxic concentrations. Archives of Toxicology 60:4, pages 293-299.
Crossref
Crossref
A.R. Dahl, L.S. Birnbaum, J.A. Bond, P.G. Gervasi & R.F. Henderson. (1987) The fate of isoprene inhaled by rats: Comparison to butadiene. Toxicology and Applied Pharmacology 89:2, pages 237-248.
Crossref
Crossref
R.L. Kanerva, M.S. McCracken, C.L. Alden & L.C. Stone. (1987) Morphogenesis of decalin-induced renal alterations in the male rat. Food and Chemical Toxicology 25:1, pages 53-61.
Crossref
Crossref
David J. Thomas, Henry L. Fisher, Martha R. Sumler, Allan H. Marcus, Paul Mushak & Larry L. Hall. (1986) Sexual differences in the distribution and retention of organic and inorganic mercury in methyl mercury-treated rats. Environmental Research 41:1, pages 219-234.
Crossref
Crossref
M.J. Angelo, A.B. Pritchard, D.R. Hawkins, A.R. Waller & A. Roberts. (1986) The pharmacokinetics of dichloromethane. I. Disposition in B6C3F1 mice following intravenous and oral administration. Food and Chemical Toxicology 24:9, pages 965-974.
Crossref
Crossref
Inga Jakobson, Bo Holmberg & Aina Ekner. (2009) Venous Blood Levels of Inhaled Trichloroethylene in Female Rats and Changes Induced by Interacting Agents. Acta Pharmacologica et Toxicologica 59:2, pages 135-143.
Crossref
Crossref
Dale B. Hattis. (2006) The Promise of Molecular Epidemiology for Quantitative Risk Assessment. Risk Analysis 6:2, pages 181-193.
Crossref
Crossref
R. Kreiling, R. J. Laib, J. G. Filser & H. M. Bolt. (1986) Species differences in butadiene metabolism between mice and rats evaluated by inhalation pharmacokinetics. Archives of Toxicology 58:4, pages 235-238.
Crossref
Crossref
Harvey J. Clewell & Melvin E. Andersen. (2016) Risk Assessment Extrapolations and Physiological Modeling. Toxicology and Industrial Health 1:4, pages 111-134.
Crossref
Crossref
John A. Buben & Ellen J. O'Flaherty. (1985) Delineation of the role of metabolism in the hepatotoxicity of trichloroethylene and perchloroethylene: A dose-effect study. Toxicology and Applied Pharmacology 78:1, pages 105-122.
Crossref
Crossref
P. H. Bach & J. W. Bridges. 1986. Receptors and Other Targets for Toxic Substances. Receptors and Other Targets for Toxic Substances
173
188
.
Alice M. Dempster, Hugh L. Evans & Carroll A. Snyder. (1984) The temporal relationship between behavioral and hematological effects of inhaled benzene. Toxicology and Applied Pharmacology 76:1, pages 195-203.
Crossref
Crossref
H. M. Bolt, J. G. Filser & F. St�rmer. (1984) Inhalation pharmacokinetics based on gas uptake studies. Archives of Toxicology 55:4, pages 213-218.
Crossref
Crossref
Michael J. Angelo, Kenneth B. Bischoff, Alan B. Pritchard & Mark A. Presser. (1984) A physiological model for the pharmacokinetics of methylene chloride in B6C3F1 mice following i.v. administrations. Journal of Pharmacokinetics and Biopharmaceutics 12:4, pages 413-436.
Crossref
Crossref
John C. Ramsey & Melvin E. Andersen. (1984) A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicology and Applied Pharmacology 73:1, pages 159-175.
Crossref
Crossref
Hartmut UehlekeDr.Dr.. (2016) Thresholds in Acute and Long Term Animal Studies. Journal of the American College of Toxicology 2:3, pages 245-268.
Crossref
Crossref
J. G. Filser, H. M. Bolt, H. Muliawan & H. Kappus. (1983) Quantitative evaluation of ethane and n-pentane as indicators of lipid peroxidation in vivo. Archives of Toxicology 52:2, pages 135-147.
Crossref
Crossref
Michael L. Gargas & Melvin E. Andersen. (1982) Metabolism of inhaled brominated hydrocarbons: Validation of gas uptake results by determination of a stable metabolite. Toxicology and Applied Pharmacology 66:1, pages 55-68.
Crossref
Crossref